Cresilon
PrivateLast Round
Seed Round
Apr 29, 2026
Est. Valuation
$93.5M
Total Funding Raised
$97.05M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cresilon is a biotechnology company that develops, manufactures, and markets hemostatic medical devices using its proprietary plant-based hydrogel technology to control bleeding.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cresilon Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Cresilon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 29, 2026 | ||||
| VC Round | Sep 9, 2025 | ||||
| Series A | Apr 11, 2025 | ||||
| Series A-4 | Oct 27, 2022 | ||||
| Series A Extension | Apr 8, 2021 | ||||
Series A Extension | Jan 22, 2019 |
Key People
Founding team and executive leadership
Cresilon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Paulson Investment Company | Series A, Series A-4 |
| Catalio Capital Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
Raised $5M in seed funding.
- Mar 25, 2026
Named to Fast Company's Most Innovative Companies list, #1 in medical devices.
Cresilon Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cresilon's valuation, stock price, and market status.